AllianceBernstein’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $822K | Sell |
35,590
-23,786
| -40% | -$549K | ﹤0.01% | 2397 |
|
|
2025
Q1 | $1.6M | Buy |
59,376
+31,736
| +115% | +$857K | ﹤0.01% | 2011 |
|
|
2024
Q4 | $1.48M | Hold |
27,640
| – | – | ﹤0.01% | 2120 |
|
|
2024
Q3 | $1.26M | Sell |
27,640
-1,600
| -5% | -$72.7K | ﹤0.01% | 2207 |
|
|
2024
Q2 | $1.22M | Buy |
29,240
+5,690
| +24% | +$238K | ﹤0.01% | 2205 |
|
|
2024
Q1 | $887K | Buy |
23,550
+6,180
| +36% | +$233K | ﹤0.01% | 2328 |
|
|
2023
Q4 | $186K | Buy |
17,370
+510
| +3% | +$5.47K | ﹤0.01% | 2992 |
|
|
2023
Q3 | $170K | Buy |
16,860
+1,830
| +12% | +$18.4K | ﹤0.01% | 2984 |
|
|
2023
Q2 | $178K | Buy |
+15,030
| New | +$178K | ﹤0.01% | 3007 |
|